Medtronic plc (NYSE:MDT) currently has a “Sell” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.
Medtronic plc (NYSE:MDT) gained 0.2 Percent and closed its previous trading session at $83.47. The stock traded with the average Volume of 5.44 Million at the end of last session.
Medtronic plc (NYSE:MDT) has the Market Capitalization of 111.84 Billion. The Stock has its 52-week High of $89.72 and 52-Week Low of $76.51 and it touched its 52-week high on 06/26/17 and 52-Week Low on 10/09/17.
The company reported its last earnings Actual EPS of $1.17/share. While, the analyst predicted that the company could provide an EPS of $1.17/share.
Sell side analysts plays vital role in buying and selling a stock where 5 analysts rated Medtronic plc (NYSE:MDT) as Buy, 1 analysts given Outperform signal, 0 reported Hold, and 0 analysts rated the stock as Sell.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 2.93% where SMA50 and SMA200 are 0.46% and 0.94% respectively.
The company shows its Return on Assets (ROA) value of 2.9%. The Return on Equity (ROE) value stands at 5.5%. While it’s Return on Investment (ROI) value is 5.7%.
Medtronic plc (NYSE:MDT) currently has a Weekly Volatility of 1.31% percent while its Monthly Volatility is at 1.88% percent. While talking about Performance of the Stock, Medtronic plc currently has a Weekly performance of 3.81%, monthly performance percentage is 5.02 percent, Quarterly performance is 2.96 percent, 6 months performance shows a percent value of 2.34% and Yearly Performance is 0.7 percent.
Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.